Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials

Mapping Intimacies ◽

10.1183/13993003.congress-2016.oa1797 ◽

2016 ◽

Author(s):

Johann Christian Virchow ◽

James Zangrilli ◽

Sivan Weiss ◽

Stephanie Korn

Keyword(s):

Controlled Trials ◽

Elevated Blood ◽

Phase 3 ◽

Two Phase ◽

Blood Eosinophils

Download Full-text

Efficacy of Reslizumab in Older Patients (≥65 years) with Asthma and Elevated Blood Eosinophils: Results from a Pooled Analysis of Two Phase 3, Placebo-Controlled Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2015.12.410 ◽

2016 ◽

Vol 137 (2) ◽

pp. AB86 ◽

Author(s):

David I. Bernstein ◽

Lyndon Mansfield ◽

James Zangrilli ◽

Margaret Garin

Keyword(s):

Older Patients ◽

Pooled Analysis ◽

Controlled Trials ◽

Elevated Blood ◽

Phase 3 ◽

Two Phase ◽

Blood Eosinophils

Download Full-text

Improvements In Individual Asthma Control Questionnaire (ACQ-5) Questions With Reslizumab In Patients With Inadequately Controlled Asthma and Elevated Blood Eosinophils: Pooled Analysis of Two Phase 3 Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2017.12.054 ◽

2018 ◽

Vol 141 (2) ◽

pp. AB17

Author(s):

Phillip E. Korenblat ◽

Mirna McDonald ◽

Margaret Garin

Keyword(s):

Asthma Control ◽

Pooled Analysis ◽

Elevated Blood ◽

Phase 3 ◽

Two Phase ◽

Asthma Control Questionnaire ◽

Blood Eosinophils

Download Full-text

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100203 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100203

Author(s):

David Muccino ◽

George Philip ◽

A.H. Morice ◽

S.S. Birring ◽

L. Mcgarvey ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Receptor Antagonist ◽

Chronic Cough ◽

Controlled Trials ◽

P2x3 Receptor ◽

Phase 3 ◽

Two Phase ◽

Randomized Controlled

Download Full-text

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00338-1 ◽

2021 ◽

Author(s):

David T Rubin ◽

Iris Dotan ◽

Aaron DuVall ◽

Yoram Bouhnik ◽

Graham Radford-Smith ◽

...

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Randomised Controlled Trials ◽

Controlled Trials ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Two Phase ◽

Randomised Controlled

Download Full-text

13767 Responder characteristics in patients with molluscum contagiosum (MC) treated with VP-102 achieving complete clearance: Pooled results of two phase 3 multicenter, randomized, vehicle-controlled trials for the topical treatment of MC

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.576 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB122

Author(s):

Lawrence F. Eichenfield ◽

Steven R. Cohen ◽

Janice L. Pelletier ◽

Pieter d’Arnaud ◽

Melissa Olivadoti ◽

...

Keyword(s):

Topical Treatment ◽

Molluscum Contagiosum ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Complete Clearance

Download Full-text

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials

American Journal of Hematology ◽

10.1002/ajh.25125 ◽

2018 ◽

Vol 93 (7) ◽

pp. 921-930 ◽

Author(s):

James Bussel ◽

Donald M. Arnold ◽

Elliot Grossbard ◽

Jiří Mayer ◽

Jacek Treliński ◽

...

Keyword(s):

Immune Thrombocytopenia ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Chronic Immune Thrombocytopenia

Download Full-text

Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.9 ◽

2021 ◽

Vol 5 (1) ◽

pp. s9

Author(s):

Jonathan Silverberg ◽

Sebastien Barbarot ◽

Melinda Gooderham ◽

Jan Simon ◽

Eric Simpson ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Double Blind ◽

Double Blind Placebo ◽

Abstract not available.

Download Full-text

767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials

Gastroenterology ◽

10.1016/s0016-5085(16)30622-9 ◽

2016 ◽

Vol 150 (4) ◽

pp. S157 ◽

Author(s):

William Sandborn ◽

Bruce E. Sands ◽

Geert R. D'Haens ◽

Severine Vermeire ◽

Stefan Schreiber ◽

...

Keyword(s):

Ulcerative Colitis ◽

Randomized Controlled Trials ◽

Induction Therapy ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Severe Ulcerative Colitis ◽

Randomized Controlled

Download Full-text

Abstract P4-16-06: Incidence of interstitial lung disease in patients with HER2-positive advanced breast cancer treated with everolimus and trastuzumab: A combined analysis of two phase 3 randomized controlled trials

10.1158/1538-7445.sabcs18-p4-16-06 ◽

2019 ◽

Author(s):

KZ Thein ◽

S Swarup ◽

A Sultan ◽

L Tijani ◽

N D'Cunha ◽

...

Keyword(s):

Breast Cancer ◽

Interstitial Lung Disease ◽

Advanced Breast Cancer ◽

Lung Disease ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Her2 Positive ◽

Phase 3 ◽

Two Phase ◽

Randomized Controlled

Download Full-text

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30427-2 ◽

2019 ◽

Vol 7 (3) ◽

pp. 213-226 ◽

Author(s):

Charles S Haworth ◽

Diana Bilton ◽

James D Chalmers ◽

Angela M Davis ◽

Juergen Froehlich ◽

...

Keyword(s):

Cystic Fibrosis ◽

Pseudomonas Aeruginosa ◽

Randomised Controlled Trials ◽

Lung Infection ◽

Controlled Trials ◽

Phase 3 ◽

Two Phase ◽

Randomised Controlled ◽

Chronic Lung Infection

Download Full-text